Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR mHealth and uHealth (no longer under consideration since Jul 16, 2021)

Date Submitted: Apr 9, 2021
Open Peer Review Period: Mar 17, 2021 - May 12, 2021
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Supporting Heart Transplantation Aftercare through Mobile Access to Medical Records: Feasibility and Usability of the App “phellow”

  • Julia Müller; 
  • Lina Weinert; 
  • Laura Svensson; 
  • Rasmus Rivinius; 
  • Michael M Kreusser; 
  • Oliver Heinze

ABSTRACT

Background:

Giving patients access to their medical records can improve health literacy, adherence to therapy, patients’ health-related self-care, doctor-patient communication, and quality of care. The application (app) phellow (“personal health fellow”) was developed to provide patients with mobile access to selected content of their medical records (i.e. physician letters, drug trough levels). It was tested at the heart transplantation (HTx) outpatient clinic at Heidelberg University Hospital among volunteer patients after heart transplantation from late 2018 onward.

Objective:

The aims of this study were (1) to assess whether the phellow app can be effectively used by all participating parties (usability) and (2) to determine if the app is feasible to be further implemented in routine care (feasibility).

Methods:

Usability was quantitatively measured through the System Usability Scale (SUS) among patients who actively used phellow. In addition, usability and feasibility were qualitatively measured through semi-structured guide-based interviews with patients (users, non-users) and health care providers (medical staff, physicians) from the HTx outpatient clinic. Quantitative data were analyzed descriptively and through correlation analyses. Qualitative data were pseudonymized, audiotaped, and transcribed verbatim. Themes were identified through thematic analysis.

Results:

The usability rating measured with the SUS questionnaire (n=31) was 79,9 (SD 14,1) which indicates a high usability. No statistically significant correlation was found between SUS scores and patients’ age, gender, or frequency or duration of phellow use. A more in-depth view on usability and feasibility was obtained from interviews with 16 patients (5 non-users, 11 users) and 7 health care providers (HCPs; 4 medical staff members, 3 physicians) (n=23). App appreciation, interest, and willingness-to-use were high. Tasks fit with clinic workflow and were perceived as clear. An improved technical support infrastructure, clearly defined responsibilities, and app-specific trainings were requested for further implementation. Usability problems such as incompleteness of record, incomprehensible presentation of content, technical issues (e.g. sudden app crashes), and complex registration procedures were reported. Participants recommended usability improvements (e.g. chronically plausible presentation of record content, simplified registration and log-in) and suggested new functionalities (e.g. access to full record, communication module, appointments, medication refill requests).

Conclusions:

Despite some usability issues, usability of the phellow app was considered high. To be feasible for an implementation in routine care, usability problems should be solved. Accompanying research is crucial to monitor usability improvements and to assess effects of app use on patients and clinic workflow.


 Citation

Please cite as:

Müller J, Weinert L, Svensson L, Rivinius R, Kreusser MM, Heinze O

Supporting Heart Transplantation Aftercare through Mobile Access to Medical Records: Feasibility and Usability of the App “phellow”

JMIR Preprints. 09/04/2021:28871

DOI: 10.2196/preprints.28871

URL: https://preprints.jmir.org/preprint/28871

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.